Scientifically Designed 4-Stage Fat Loss Supplement Offers Safe, Non-Prescription Alternative to GLP-1 Drugs Like ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

A new Canadian guideline urges lifestyle interventions for obese children but also says today's new drugs might help kids ...

Pfizer said it will stop development of an oral weight-loss pill after a participant taking the drug in a clinical trial ...

Forward-looking: The rising popularity of GLP-1 receptor agonists like Ozempic and Wegovy has transformed obesity treatment and spurred competition among pharmaceutical companies to develop more ...

In summary, GLP-1 receptor agonists, originally used to treat diabetes, are now being explored for brain protection. Two ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

A new study led by researchers at the Arkansas Agricultural Experiment Station has found that the popular class of weight-loss drugs known as GLP-1 agonists—including Mounjaro, Ozempic, and Wegovy—is ...

A study led by two undergraduate students at the University of Galway found that GLP-1 receptor agonists, a type of diabetes ...

The study supports prior research that found the same thing.

Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...